Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
96.95
Dollar change
-2.05
Percentage change
-2.07
%
Index- P/E202.53 EPS (ttm)0.48 Insider Own0.25% Shs Outstand237.73M Perf Week7.00%
Market Cap23.05B Forward P/E- EPS next Y-2.11 Insider Trans0.00% Shs Float237.14M Perf Month11.81%
Income117.93M PEG- EPS next Q-2.24 Inst Own17.80% Short Float1.44% Perf Quarter3.67%
Sales2.95B P/S7.81 EPS this Y-141.64% Inst Trans12.40% Short Ratio5.18 Perf Half Y-1.03%
Book/sh90.72 P/B1.07 EPS next Y-22.32% ROA0.49% Short Interest3.42M Perf Year-12.73%
Cash/sh40.78 P/C2.38 EPS next 5Y- ROE0.54% 52W Range85.21 - 125.83 Perf YTD-8.14%
Dividend Est.- P/FCF3.99 EPS past 5Y- ROI0.54% 52W High-22.95% Beta0.26
Dividend TTM- Quick Ratio11.16 Sales past 5Y843.27% Gross Margin79.32% 52W Low13.77% ATR (14)3.09
Dividend Ex-DateJun 02, 2022 Current Ratio11.38 EPS Y/Y TTM-98.06% Oper. Margin-13.07% RSI (14)59.05 Volatility5.08% 3.15%
Employees3082 Debt/Eq0.01 Sales Y/Y TTM-76.62% Profit Margin4.00% Recom2.43 Target Price115.19
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-164.64% Payout0.00% Rel Volume1.88 Prev Close99.00
Sales Surprise-57.48% EPS Surprise-6.12% Sales Q/Q-85.14% EarningsMay 06 BMO Avg Volume661.32K Price96.95
SMA205.17% SMA506.72% SMA200-2.62% Trades Volume1,245,177 Change-2.07%
Date Action Analyst Rating Change Price Target Change
May-14-24Initiated Evercore ISI In-line $100
Feb-23-24Initiated BMO Capital Markets Outperform $127
Jan-05-24Initiated Oppenheimer Perform
Dec-01-23Downgrade JP Morgan Neutral → Underweight $106 → $99
Oct-16-23Downgrade HSBC Securities Buy → Hold $124 → $111
Jul-14-23Initiated HSBC Securities Buy $124
May-17-23Upgrade Redburn Neutral → Buy $165 → $170
Dec-15-22Upgrade BofA Securities Neutral → Buy $239
Aug-17-22Initiated Cowen Market Perform $177
Jul-13-22Upgrade SVB Leerink Mkt Perform → Outperform
May-24-24 12:16PM
08:15AM
May-21-24 06:45AM
04:00AM
May-20-24 02:09PM
02:42AM Loading…
May-18-24 02:42AM
May-17-24 02:46PM
01:17PM
12:36PM
11:15AM
May-14-24 07:58AM
May-07-24 11:26AM
06:22AM
05:08AM
May-06-24 04:14PM
04:04PM Loading…
04:04PM
02:30PM
12:11PM
12:02PM
11:53AM
10:16AM
08:57AM
08:15AM
07:31AM
07:23AM
07:03AM
07:03AM
06:49AM
06:45AM
May-03-24 10:08AM
11:58AM Loading…
Apr-30-24 11:58AM
Apr-25-24 01:51PM
01:28PM
12:55PM
11:27AM
09:54AM
09:39AM
Apr-23-24 07:21AM
Apr-22-24 06:08PM
06:45AM
Apr-07-24 02:00PM
Mar-31-24 03:39PM
Mar-26-24 09:53AM
06:44AM
01:00AM
Mar-25-24 06:47AM
06:19AM
Mar-21-24 11:38AM
01:43AM
Mar-20-24 04:45PM
03:56PM
03:38PM
02:45PM
11:05AM
10:34AM
09:20AM
09:09AM
07:49AM
06:22AM
06:17AM
06:15AM
06:15AM
06:00AM
Mar-17-24 09:19AM
08:50AM
Mar-15-24 05:53AM
Mar-14-24 01:51PM
Mar-13-24 11:07AM
Mar-11-24 03:29PM
07:45AM
Mar-09-24 01:09PM
Mar-08-24 01:25AM
Mar-07-24 06:45AM
Mar-06-24 04:45PM
06:45AM
Mar-05-24 04:16AM
Mar-04-24 06:42PM
05:33PM
10:06AM
Mar-02-24 10:42AM
Feb-27-24 05:45AM
Feb-26-24 12:29PM
10:27AM
Feb-23-24 01:00PM
Feb-14-24 06:35PM
Feb-08-24 06:07AM
05:45AM
Feb-04-24 06:56AM
Feb-02-24 02:39PM
Feb-01-24 06:30AM
Jan-31-24 06:45AM
Jan-25-24 09:55AM
Jan-24-24 11:30AM
Jan-22-24 06:45AM
06:45AM
Jan-17-24 11:30AM
Jan-09-24 04:16PM
07:37AM
07:12AM
07:09AM
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.